The reported statements, read against the company's own industry.
What stands out
Valued far above the size of its business
Financials view
Market Capitalization
2.92BNOK
307.45M · vs all stocks (USD)
Updated Nov 17, 2026
Revenue (TTM)
560.78MNOK
60.48M · vs all stocks (USD)
Updated Nov 17, 2026
Profit Margin
-29.94%
vs Health Information Services peers
Updated Nov 17, 2026
Beta
0.2980x
vs all stocks
Updated Nov 17, 2026
52-Week Change
-23.86%
vs all stocks
Updated Nov 17, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Nov 17, 2026
Market Capitalization
2.92BNOK
307.45M · vs all stocks (USD)
Updated Nov 17, 2026
Enterprise Value
19.85BNOK
2.02B · vs all stocks (USD)
Updated Nov 17, 2026
Forward P/E
41.50x
vs Health Information Services peers
Updated Nov 17, 2026
Price to Sales (TTM)
38.86x
vs Health Information Services peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 5.2×.Updated Nov 17, 2026
Price to Book (MRQ)
3.19x
vs Health Information Services peers
Updated Nov 17, 2026
Enterprise to Revenue
35.40x
vs Health Information Services peers
Updated Nov 17, 2026
Gross Margin
76.85%
vs Health Information Services peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 23.57%.Updated Nov 17, 2026
Profit Margin
-29.94%
vs Health Information Services peers
Updated Nov 17, 2026
Operating Margin
-25.64%
vs Health Information Services peers
Updated Nov 17, 2026
Return on Assets (TTM)
-12.63%
vs Health Information Services peers
Updated Nov 17, 2026
Return on Equity (TTM)
-25.82%
vs Health Information Services peers
Updated Nov 17, 2026
Revenue (TTM)
560.78MNOK
60.48M · vs all stocks (USD)
Updated Nov 17, 2026
Revenue per Share (TTM)
0.6740NOKUpdated Nov 17, 2026
Quarterly Revenue Growth
10.20%
vs Health Information Services peers
Updated Nov 17, 2026
Gross Profit (TTM)
132.16MNOK
14.46M · vs all stocks (USD)
Updated Nov 17, 2026
EBITDA (TTM)
-110.90MNOK
-9.08M · vs all stocks (USD)
Updated Nov 17, 2026
Net Income (TTM)
-167.87MNOK
-17.74M · vs all stocks (USD)
Updated Nov 17, 2026
Quarterly Earnings Growth (YoY)
10.22%
vs Health Information Services peers
Updated Nov 17, 2026
Operating Cash Flow (TTM)
-25.32MNOK
-1.78M · vs all stocks (USD)
Updated Nov 17, 2026
Levered Free Cash Flow (TTM)
-20.05MNOK
-1.77M · vs all stocks (USD)
Updated Nov 17, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Nov 17, 2026
Trailing Annual Dividend Rate
0.00NOKUpdated Nov 17, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Nov 17, 2026
Payout Ratio
0.00%
vs Health Information Services peers
Updated Nov 17, 2026
Revenue
50.84MEURFY2025 · Dec 31, 2025
Cost of Goods Sold
9.54MEURFY2025 · Dec 31, 2025
Gross Profit
41.30MEURFY2025 · Dec 31, 2025
Operating Income
-12.47MEUR
-14.39M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-12.29MEURFY2025 · Dec 31, 2025
Income Tax Expense
389.00KEURFY2025 · Dec 31, 2025
Net Income
-12.68MEURFY2025 · Dec 31, 2025
EBIT
-12.25MEURFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-965.00KEURFY2025 · Dec 31, 2025
Other Operating Expenses
14.97MEURFY2025 · Dec 31, 2025
Non-operating Interest Income
961.00KEURFY2025 · Dec 31, 2025
Non-operating Interest Expense
44.00KEURFY2025 · Dec 31, 2025
EPS (Basic)
-0.1609EURFY2025 · Dec 31, 2025
EPS (Diluted)
-0.1609EURFY2025 · Dec 31, 2025
Basic Shares Outstanding
78.81MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
78.81MSharesFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00EURFY2025 · Dec 31, 2025
Operating Cash Flow
-9.52MEURFY2025 · Dec 31, 2025
Free Cash Flow
-14.61MEURFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
4.36MEURFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-12.29MEURFY2025 · Dec 31, 2025
Other Non-cash Items
2.08MEURFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
713.00KEURFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-21.00KEURFY2025 · Dec 31, 2025
Capital Expenditures
-5.09MEURFY2025 · Dec 31, 2025
Purchase of Investments
0.00EURFY2025 · Dec 31, 2025
Sale of Investments
5.50MEURFY2025 · Dec 31, 2025
Net Investing Cash Flow
402.00KEURFY2025 · Dec 31, 2025
Common Stock Repurchase
-885.00KEURFY2025 · Dec 31, 2025
Net Financing Cash Flow
-885.00KEURFY2025 · Dec 31, 2025
Shares Outstanding
78.81MSharesUpdated Nov 17, 2026
Float Shares
42.12MSharesUpdated Nov 17, 2026
% Held by Insiders
6.17%
vs all stocks
Updated Nov 17, 2026
% Held by Institutions
8.80%
vs all stocks
Updated Nov 17, 2026
Total Cash (MRQ)
131.92MNOK
17.46M · vs all stocks (USD)
Updated Nov 17, 2026
Total Cash per Share (MRQ)
0.1580NOKUpdated Nov 17, 2026
Total Debt (MRQ)
0.00NOK
vs all stocks (USD)
Updated Nov 17, 2026
Total Debt to Equity (MRQ)
0.00x
vs Health Information Services peers
Updated Nov 17, 2026
Current Ratio (MRQ)
1.60x
vs Health Information Services peers
Updated Nov 17, 2026
Book Value per Share (MRQ)
8.22NOKUpdated Nov 17, 2026
Total Assets
71.53MEUR
82.55M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
22.04MEURFY2025 · Dec 31, 2025
Total Liabilities
9.97MEURFY2025 · Dec 31, 2025
Total Non-current Assets
49.49MEURFY2025 · Dec 31, 2025
Total Non-current Liabilities
7.00KEURFY2025 · Dec 31, 2025
Total Current Liabilities
9.96MEURFY2025 · Dec 31, 2025
Cash
4.36MEURFY2025 · Dec 31, 2025
Cash & Cash Equivalents
4.36MEURFY2025 · Dec 31, 2025
Other Short-term Investments
10.34MEURFY2025 · Dec 31, 2025
Accounts Receivable
5.03MEURFY2025 · Dec 31, 2025
Accounts Payable
1.52MEURFY2025 · Dec 31, 2025
Other Current Liabilities
1.75MEURFY2025 · Dec 31, 2025
Other Non-current Liabilities
7.00KEURFY2025 · Dec 31, 2025
Total Shareholders' Equity
61.56MEUR
71.04M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
21.20NOKUpdated Nov 17, 2026
52-Week High
38.40NOKUpdated Nov 17, 2026
52-Week Change
-23.86%
vs all stocks
Updated Nov 17, 2026
Beta
0.2980x
vs all stocks
Updated Nov 17, 2026
50-Day MA
25.65NOKUpdated Nov 17, 2026
200-Day MA
26.09NOKUpdated Nov 17, 2026
Avg 10-Day Volume
19.93KSharesUpdated Nov 17, 2026
Avg 30-Day Volume
8.47KSharesUpdated Nov 17, 2026
Diluted EPS (TTM)
-2.26NOKUpdated Nov 17, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Goodwill-Heavy Asset Growth With a Recent Reversal
Assets grew over the long run on acquired goodwill, but have shrunk in each of four years.
Reads
Diagnostic
Goodwill-Heavy Equity
Equity looks heavy for the industry, but much of it is goodwill from past acquisitions.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Debt-to-equity is 0×, lower than 95% of its Health Information Services peers (median 0.13×)Notable